{"doi":"10.1155/2018/1232785","title":"Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure","abstract":"<jats:p><jats:italic>Background and Aims</jats:italic>. The value of alpha-fetoprotein (AFP) in hepatitis B-related acute-on-chronic liver failure (HBACLF) is not fully understood. The present study aimed to evaluate the prognostic effect of AFP on the prediction of HBACLF outcomes.<jats:italic> Methods</jats:italic>. We investigated a cohort of patients with HBACLF admitted from January 2013 to May 2017. The endpoint of followup was 180 days, death, or liver transplantation. AFP concentrations were estimated on admission. To make statistical comparisons, we used chi-squared test, receiver operating characteristic (ROC) curve analysis, survivorship curve analysis, and Cox proportional-hazards model.<jats:italic> Results</jats:italic>. A total of 92 patients (81.5% male, median age of 46 years) were included. Overall survival rate within 180 days was 43.48%, and the value of <mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" id=\"M1\"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">log</mml:mi></mml:mrow><mml:mrow><mml:mn fontstyle=\"italic\">10</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">AFP</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo> </mml:mo></mml:mrow></mml:mrow></mml:math> ≥ 2.04 indicated a better prognosis with 76.9% specificity and 62.5% sensitivity for patients with HBACLF. Age (HR 1.041), total bilirubin (HR 1.004), <mml:math xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" id=\"M2\"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">log</mml:mi></mml:mrow><mml:mrow><mml:mn fontstyle=\"italic\">10</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">AFP</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo> </mml:mo></mml:mrow></mml:mrow></mml:math> (HR 2.155), and INR (HR 1.446) were found to be risk factors of survival.<jats:italic> Conclusion</jats:italic>. AFP could be a useful marker to predict outcomes of acute-on-chronic liver failure.</jats:p>","journal":"Canadian Journal of Gastroenterology and Hepatology","year":2018,"id":29500,"datarank":1.0555543832480812,"base_score":3.044522437723423,"endowment":3.044522437723423,"self_citation_contribution":0.4566783656585135,"citation_network_contribution":0.5988760175895677,"self_endowment_contribution":0.4566783656585135,"citer_contribution":0.5988760175895677,"corpus_percentile":null,"corpus_rank":null,"citation_count":20,"citer_count":19,"citers_with_citation_signal":16,"citers_with_endowment":16,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":162530,"name":"Caifei Shen","orcid":null,"position":1,"is_corresponding":false},{"id":162531,"name":"Jianjiang Yang","orcid":null,"position":2,"is_corresponding":false},{"id":162532,"name":"Xianjun Yang","orcid":null,"position":3,"is_corresponding":false},{"id":162533,"name":"Sen Qin","orcid":null,"position":4,"is_corresponding":false},{"id":162534,"name":"Haijun Zeng","orcid":null,"position":5,"is_corresponding":false},{"id":162535,"name":"Xiaoling Wu","orcid":null,"position":6,"is_corresponding":false},{"id":162536,"name":"Shanhong Tang","orcid":"0000-0002-9617-6769","position":7,"is_corresponding":false},{"id":162537,"name":"Weizheng Zeng","orcid":"0000-0002-9631-6039","position":8,"is_corresponding":false},{"id":162529,"name":"Xiaoping Wang","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.044522437723423,"endowment":3.044522437723423,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29854714","pmcid":"PMC5966688","openalex_id":"https://openalex.org/W2801581376","authors":[],"funders":[{"funder_name":"National Natural Science Foundation of China","grant_id":"81401993","title":null}],"total_grants":1,"fwci":0.9764,"citation_percentile":0.75946754,"influential_citations":0,"citation_trend":[{"year":2020,"count":3},{"year":2021,"count":3},{"year":2022,"count":3},{"year":2023,"count":3},{"year":2024,"count":2},{"year":2025,"count":5}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"http://downloads.hindawi.com/journals/cjgh/2018/1232785.pdf","host_type":"journal"},{"url":"http://downloads.hindawi.com/journals/cjgh/2018/1232785.pdf","host_type":"GOLD"},{"url":"http://downloads.hindawi.com/journals/cjgh/2018/1232785.pdf","host_type":"publisher"},{"url":"http://downloads.hindawi.com/journals/cjgh/2018/1232785.xml","host_type":"publisher"},{"url":"https://doi.org/10.1155/2018/1232785","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29854714","host_type":"repository"},{"url":"https://doaj.org/article/9f5c82c188a248bcb27b748b8fec438f","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5966688","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC5966688","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC5966688?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Hepatitis B Virus Studies","Liver Disease and Transplantation","Liver Disease Diagnosis and Treatment","Medicine","Acute-On-Chronic Liver Failure","Adolescent","Adult","Aged","Biomarkers","China","Female","Follow-Up Studies","Hepatitis B, Chronic","Humans","Incidence","Male","Middle Aged","Predictive Value of Tests","Prognosis","Retrospective Studies","Risk Factors","Survival Rate","Young Adult","alpha-Fetoproteins"],"mesh_terms":["Adolescent","Adult","Aged","alpha-Fetoproteins","China","Female","Follow-Up Studies","Humans","Male","Middle Aged","Predictive Value of Tests","Prognosis","Retrospective Studies","Risk Factors","Biomarkers","Incidence","Survival Rate","Hepatitis B, Chronic","Young Adult","Acute-On-Chronic Liver Failure"],"keywords":["Medicine","Liver failure","Chronic hepatitis","Predictive marker","Internal medicine","Gastroenterology","Hepatitis B","Intensive care medicine","Immunology","Virus","Cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-09T00:01:19.261433Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}